Strategic Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9K Buy
222
+7
+3% +$980 ﹤0.01% 611
2025
Q4
$26.4K Sell
215
-49
-19% -$5.96K ﹤0.01% 639
2025
Q3
$29.3K Hold
264
﹤0.01% 657
2025
Q2
$29.3K Buy
+264
New +$28.1K ﹤0.01% 581
2024
Q1
Sell
-7,950
Closed -$644K 293
2023
Q4
$644K Sell
7,950
-23,534
-75% -$1.83M 0.08% 161
2023
Q3
$2.36M Sell
31,484
-3,586
-10% -$276K 0.31% 92
2023
Q2
$2.7M Sell
35,070
-708
-2% -$56.5K 0.35% 88
2023
Q1
$2.97M Sell
35,778
-1,034
-3% -$85.6K 0.46% 61
2022
Q4
$3.16M Sell
36,812
-32,495
-47% -$2.57M 0.59% 48
2022
Q3
$4.28M Sell
69,307
-411
-0.6% -$25.9K 0.91% 22
2022
Q2
$4.31M Sell
69,718
-2,051
-3% -$127K 0.93% 21
2022
Q1
$4.27M Sell
71,769
-5,016
-7% -$321K 0.83% 28
2021
Q4
$5.58M Buy
+76,785
New +$5.29M 1.06% 18
2019
Q4
Sell
-2,125
Closed -$46K 271
2019
Q3
$46K Buy
2,125
+556
+35% +$36.3K 0.24% 84
2019
Q2
$105K Buy
1,569
+446
+40% +$29.3K 0.05% 171
2019
Q1
$74K Buy
1,123
+135
+14% +$8.97K 0.03% 203
2018
Q4
$68K Sell
988
-56
-5% -$3.91K 0.03% 205
2018
Q3
$81K Hold
1,044
0.04% 191
2018
Q2
$74K Sell
1,044
-549
-34% -$38.8K 0.04% 221
2018
Q1
$120K Sell
1,593
-8,980
-85% -$714K 0.06% 176
2017
Q4
$773K Buy
+10,573
New +$803K 0.43% 82

Other funds holding GILD

Strategic Wealth Partners's GILD Position: Q1 2026 in Review

Strategic Wealth Partners increased its Gilead Sciences (GILD) stake by 3.3% in Q1 2026, buying an estimated $980 and bringing the position to 222 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Strategic Wealth Partners first reported a position in GILD in Q4 2017 and has held it in 21 quarters since. The position peaked at $5.58M in Q4 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Strategic Wealth Partners held 222 shares of Gilead Sciences worth $30.9K as of Q1 2026.
  • Strategic Wealth Partners bought 7 Gilead Sciences shares in Q1 2026, an estimated $980.
  • Gilead Sciences made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q1 2026, its #611 holding.
  • Strategic Wealth Partners first reported a position in Gilead Sciences in Q4 2017 and has held it in 21 quarters since.
  • Strategic Wealth Partners's Gilead Sciences position peaked at $5.58M in Q4 2021.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.